Noninvasive DNA testing via liquid biopsy
When it comes to cancer care, DNA tumor testing is vital to providing individualized treatment. Mayo Clinic Laboratories’ liquid biopsy is a noninvasive alternative to traditional cell-based biopsies. Liquid biopsies allow for faster turnaround time and the ability to perform molecular testing in patients where tumor tissue isn’t available.
The MayoComplete Liquid Biopsy Panel (Mayo ID: MCLBP) detects single nucleotide variants, insertions, and deletions in 33 target genes and assesses gene amplifications, translocations, and microsatellite instability.